Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/Philippines FDA/Vaspin

Approved

STANDARD

Vaspin

Magbro Healthcare Pvt. Ltd.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 7162ea46ed5a1243
Company: Magbro Healthcare Pvt. Ltd.
Type: Standard

Approval Details

Approval Id: 7162ea46ed5a1243
Drug Approval Philippines Name: Vaspin
Product Name: Vaspin
Registration Number: DRP-13491
Brand Name: Vaspin
Generic Name: Valsartan + Amlodipine (as besilate)
Dosage Form: Film-Coated Tablet
Dosage Strength: 160 mg/5 mg
Manufacturer: Magbro Healthcare Pvt. Ltd.
Importer: Pharmakon Biotec, Inc.
Distributor: Pharmakon Biotec, Inc.
Issuance Date: 27 February 2023
Expiry Date: 27 February 2028
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

7162ea46ed5a1243

Type

Standard

Back to Philippines FDA Approvals

Vaspin - Philippines FDA Drug Approval Details